Weight Loss News
-
A hormone treatment based on technology used in Pfizer Inc.’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
-
Barbara Buono, the Democrat trying to oust New Jersey Governor Chris Christie, is so low on funds that her campaign ads don’t reach voters via television or radio. To see them, you must go to her website, Facebook or Twitter page.
-
The National Association of Attorneys General has asked the U.S. Food and Drug Administration to place a “black box warning” on labels of the opioid category of prescription-pain relievers to alert pregnant women that use of such drugs may harm infants.
-
In India, where one-in-six people are undernourished, an unlikely business is booming: obesity surgery.
-
New Jersey Governor Chris Christie, a possible 2016 presidential candidate who has been the butt of jokes about his waistline, acknowledged having weight-loss surgery in February, calling it a “private” matter.
-
New Jersey Governor Chris Christie’s acknowledgment of having secret stomach surgery may reassure voters who’ve wondered whether he’s fit to be president.
-
Arena Pharmaceuticals Inc.’s Belviq, the weight-loss pill approved in June by the U.S. Food and Drug Administration, was cleared to start sales next month after a separate review found the drug’s abuse potential to be low.
-
Want Viagra without the inconvenience and potential embarrassment of the pharmacy line?
-
Arena Pharmaceuticals Inc., the maker of the weight-loss drug Belviq, said it is withdrawing its application to gain regulatory approval in Europe for the obesity medicine.
-
Jawbone, the maker of wireless audio and fitness-tracking devices, is buying BodyMedia Inc. for $110 million, according to people with knowledge of the deal’s price.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page